Sadaf Aghevlian

Sadaf Aghevlian, PhD has a diverse work experience in various scientific and research roles. Sadaf is currently working as a Computational Scientist at Fusion Pharmaceuticals since March 2022. In their previous role at Fusion Pharmaceuticals as a Research Scientist II/ Team Lead from January 2021 to March 2022, they successfully led a pre-clinical sub-team, designed and conducted translational research, and authored research-related regulatory documents.

Prior to their role at Fusion Pharmaceuticals, Sadaf was a Postdoctoral Research Fellow at Stanford University School of Medicine from July 2019 to January 2021. In this position, they focused on PET imaging of tumor-infiltrating immune cells and tracking engineered adeno-associated virus (AAVs) using PET imaging.

Before their postdoctoral fellowship, Sadaf worked at the University of Toronto in two different roles. From July 2018 to April 2019, they served as a Regulatory Affairs Assistant. Prior to this, they worked as a Teaching Assistant from September 2015 to August 2018.

Sadaf also gained experience as a Market Research Intern at TO Health! from January 2017 to June 2017.

Overall, Sadaf Aghevlian, PhD has a strong background in computational science, pre-clinical research, regulatory affairs, teaching, and market research.

Sadaf Aghevlian, PhD completed their education in the field of pharmaceutical sciences. Sadaf pursued their Doctor of Philosophy (PhD) from the University of Toronto, graduating in 2019. Prior to that, they briefly studied radiation oncology at the University of Oxford in 2013. Before their time at Oxford, Sadaf completed their Master of Science (M.Sc.) in Medical Radiation Engineering at Shiraz University. The start and end years for this degree are not specified.